Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2019 | 08-2019 | 05-2019 | 11-2018 | |
| Sales | 0 | 10,580 | 0 | 0 |
| Gross Profit | N/A | 10,580 | 0 | N/A |
| Operating Expenses | 0 | 13,192 | 0 | 0 |
| Operating Income | N/A | -2,612 | N/A | N/A |
| Other Income | 0 | 195 | 0 | 0 |
| Pre-tax Income | 0 | -2,417 | 0 | 0 |
| Income Tax | N/A | 10 | 0 | N/A |
| Net Income Continuous | N/A | -2,427 | 0 | N/A |
| Net Income | $N/A | $-2,427 | $0 | $N/A |
| EPS Basic Total Ops | N/A | -0.66 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -0.66 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.66 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -0.66 | N/A | N/A |
| EBITDA(a) | $N/A | $-2,059 | $N/A | $N/A |